Autophagy: an Emerging Therapeutic Target in Human Disease Workshop and Symposium
Friday, February 17, 2012 8:30AM - 4:30PM
Autophagy: an Emerging Therapeutic Target in Human Disease Workshop
Simon Fraser Harbour Centre (downtown campus)
This day long workshop will feature presentations by research groups carrying out work related to autophagy and cancer. Workshop Agenda now available to view.
Two Keynote addresses will be given :
9:30 - 10:30 Dr. Natalie D'Amore, Associate Director of Molecular and Cellular Oncology for Millennium: The Takeda Oncology Company
3:30 - 4:30 Dr. Ravi Amaravadi, Assistant Professor of Medicine at the University of Pennsylvania
A scientific poster session will be held during the day, and a cash award for the best student poster will be presented.
Discussions will be moderated by: Dr. Sharon Gorski (Simon Fraser University, BC Cancer Agency), Prof. Robert Young (Merck Frosst - B.C. Discovery Chair in Pharmareutical Genomics, Bioinformatics and Drug Discovery, Simon Fraser University), Dr. Julian Lum (BC Cancer Agency - Deeley Research Centre). Prof. Tessa Holyoake, University of Glasgow will be participating.
Saturday, February 18, 2012 1:30PM - 4:30PM
AAAS 2012 Annual Meeting Symposium Track: Discovery
Autophagy: an Emerging Therapeutic Target in Human Disease
Vancouver Convention Center
Register at www.aaas.org
Moderator: Sharon M. Gorski, BC Cancer Agency and Simon Fraser University
Natalie D'Amore, Millennium: The Takeda Oncology Company Autophagy Research: An Industrial Perspective
Tessa Holyoake, University of Glasgow Targeting the Autophagy Pathways in Chronic Myeloid Leukemia Stem Cells
Robert N. Young, Simon Fraser University Novel Assays and Inhibitors of the Key Autophagy Protease
Ravi Amaravadi, University of Pennsylvania Autophagy Inhibition in Cancer Therapy: Progress and Unanswered Questions
For further information contact:
Stephanie McInnis, Project Manager
Genome Sciences Centre, BC Cancer Agency
Phone: 604-675-8000 x 7965